Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer
Open Access
- 2 December 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (12), e0242145
- https://doi.org/10.1371/journal.pone.0242145
Abstract
Although circulating cell-free DNA (cfDNA) is a promising biomarker for the diagnosis and prognosis of various tumors, clinical correlation of cfDNA with gastric cancer has not been fully understood. To address this, we developed a highly sensitive cfDNA capture system by integrating polydopamine (PDA) and silica. PDA-silica hybrids incorporated different molecular interactions to a single system, enhancing cfDNA capture by 1.34-fold compared to the conventional silica-based approach (p = 0.001), which was confirmed using cell culture supernatants. A clinical study using human plasma samples revealed that the diagnostic accuracy of the new system to be superior than the commercially available cfDNA kit, as well as other serum antigen tests. Among the cancer patients, plasma cfDNA levels exhibited a good correlation with the size of a tumor. cfDNA was also predicative of distant metastasis, as the median cfDNA levels of metastatic cancer patients were ~60-fold higher than those without metastasis (p = 0.008). Furthermore, high concordance between tissue biopsy and cfDNA genomic analysis was found, as HER2 expression in cfDNA demonstrated an area under ROC curve (AUC) of 0.976 (p <0.001) for detecting patients with HER2-positive tumors. The new system also revealed high prognostic capability of cfDNA, as the concentration of cfDNA was highly associated with the survival outcomes. Our novel technology demonstrates the potential to achieve efficient detection of cfDNA that may serve as a reliable biomarker for gastric tumor.Keywords
Funding Information
- Wisconsin Head & Neck Cancer SPORE (P50-DE026787)
This publication has 30 references indexed in Scilit:
- HER-2 incidence in gastric cancer, its association with prognosis and clinicopathological parametersTurkish Journal of Surgery, 2015
- Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene AmplificationJournal of Circulating Biomarkers, 2015
- DNA Binding to the Silica SurfaceThe Journal of Physical Chemistry B, 2015
- Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patientsBMC Cancer, 2014
- Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapyIUBMB Life, 2013
- Multiphasic DNA Adsorption to Silica Surfaces under Varying Buffer, pH, and Ionic Strength ConditionsThe Journal of Physical Chemistry B, 2012
- High-Sensitivity C-Reactive Protein and CancerJournal of Epidemiology, 2011
- Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancerEuropean Respiratory Journal, 2010
- Silica-coated alginate beads for in vitro protein synthesis via transcription/translation machinery encapsulationJournal of Biotechnology, 2009
- A facile method of surface modification for hydrophobic polymer membranes based on the adhesive behavior of poly(DOPA) and poly(dopamine)Journal of Membrane Science, 2008